GO
Loading...

Diversifying your pharma portfolio

Monday, 7 Apr 2014 | 1:07 PM ET

Mallinckrodt is buying drug maker Questcor for $5.6 billion. Barbara Ryan, FTI Consulting managing director, discusses consolidation in pharmaceuticals and shares what stocks she likes in the space.